SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
1220.35 EUR
In Stock
quantity
Produktdetaljer
Katalognummer: 223 - 20-235
Produktkategori: Företag och industri > Vetenskap och laboratorium
Gentaur
Storlek: 0.1 mg
20-190
SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
SARS-CoV-2 (COVID-19) ORF9B Recombinant Protein
1220.35 €
9191-002mg
SARS-CoV-2 (COVID-19) ORF9b Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3).
474.55 €
9191-01mg
SARS-CoV-2 (COVID-19) ORF9b Antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. ORF9b plays a role in the inhibition of host innate immune response by targeting the mitochondrial-associated adapter MAVS. Mechanistically, it usurps the E3 ligase ITCH to trigger the degradation of MAVS, TRAF3, and TRAF6. In addition, it causes mitochondrial elongation by triggering ubiquitination and proteasomal degradation of dynamin-like protein 1/DNM1L(3).
1021.39 €
20-230
SARS-CoV-2 (COVID-19) Membrane Recombinant Protein
SARS-CoV-2 (COVID-19) Membrane Recombinant Protein
1220.35 €
20-231
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein
SARS-CoV-2 (COVID-19) Envelope Recombinant Protein
1220.35 €
20-233
SARS-CoV-2 (COVID-19) Spike Recombinant Protein
SARS-CoV-2 (COVID-19) Spike Recombinant Protein